Solid-phase enzyme modification via affinity chromatography

被引:14
作者
Baran, ET
Özer, N
Hasirci, V [1 ]
机构
[1] Middle E Tech Univ, Dept Biol Sci, Biotechnol Res Unit, TR-06531 Ankara, Turkey
[2] Hacettepe Univ, Fac Med, Dept Biochem, TR-06100 Ankara, Turkey
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2003年 / 794卷 / 02期
关键词
enzymes; L-asparaginase;
D O I
10.1016/S1570-0232(03)00487-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In the present study antileukemic enzyme L-asparaginase (ASNase) and catalase (as a model enzyme) were modified in solid-phase with activated polyethylene glycol (PEG,) by using ligand-immobilized affinity column systems L-asparagine-Sepharose CL-4B and Procion red-Sepharose CL-4B, respectively. Studies on change of specific activity with modification time showed negligible differences between batches of modified catalase. Modification of ASNase for I It resulted in 50.2% recovery of the specific activity and the attachment of 69 molecules of PEG(2) per molecule of ASNase forming 'PEGylated ASNase'. Sequential modification of ASNase by activated PEG and heparin resulted in coupling of about nine molecules of heparin per molecule of PEGylated ASNase. Intravenous (i.v.) administration of PEG(2)-modified ASNase showed prolonged presence in the blood circulation and no adverse effects or symptoms of anaphylaxis were observed in presensitized mice. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:311 / 322
页数:12
相关论文
共 32 条
[1]  
AEBI H, 1984, METHOD ENZYMOL, V105, P121
[2]   PHARMACOKINETICS OF PEG-L-ASPARAGINASE AND PLASMA AND CEREBROSPINAL-FLUID L-ASPARAGINE CONCENTRATIONS IN THE RHESUS-MONKEY [J].
BERG, SL ;
BALIS, FM ;
MCCULLY, CL ;
GODWIN, KS ;
POPLACK, DG .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 32 (04) :310-314
[3]   IMMOBILIZATION-STABILIZATION OF ENZYMES - VARIABLES THAT CONTROL THE INTENSITY OF THE TRYPSIN (AMINE) AGAROSE (ALDEHYDE) MULTIPOINT ATTACHMENT [J].
BLANCO, RM ;
CALVETE, JJ ;
GUISAN, JM .
ENZYME AND MICROBIAL TECHNOLOGY, 1989, 11 (06) :353-359
[4]   Catalytic biofunctional membranes containing site-specifically immobilized enzyme arrays: a review [J].
Butterfield, DA ;
Bhattacharyya, D ;
Daunert, S ;
Bachas, L .
JOURNAL OF MEMBRANE SCIENCE, 2001, 181 (01) :29-37
[5]  
FORTIER G, 1993, BIOTECHNOL APPL BIOC, V17, P115
[6]   POLYCLONAL ANTI-CHYMOTRYPSIN ANTIBODIES SUITABLE FOR ORIENTED IMMOBILIZATION OF CHYMOTRYPSIN [J].
FUSEK, M ;
TURKOVA, J ;
STOVICKOVA, J ;
FRANEK, F .
BIOTECHNOLOGY LETTERS, 1988, 10 (02) :85-90
[7]   PEG drugs: an overview [J].
Greenwald, RB .
JOURNAL OF CONTROLLED RELEASE, 2001, 74 (1-3) :159-171
[8]  
INADA Y, 1994, METHOD ENZYMOL, V242, P65
[9]   SIMPLE AND RAPID METHOD FOR ESTIMATION OF L-ASPARAGINASE IN CHROMATOGRAPHIC AND ELECTROPHORETIC EFFLUENTS - COMPARISON WITH OTHER METHODS [J].
JAYARAM, HN ;
COONEY, DA ;
JAYARAM, S ;
ROSENBLU.L .
ANALYTICAL BIOCHEMISTRY, 1974, 59 (02) :327-346
[10]  
JORGE JCS, 1994, CANCER CHEMOTH PHARM, V34, P230